JAMA Psychiatry Randomized Clinical Trial A landmark randomized clinical trial published in JAMA Psychiatry found that weekly subcutaneous injections of semaglutide, compared to placebo injections, reduced alcohol craving, drinking episodes, and the number of heavy drinking days in adults diagnosed with alcohol use disorder
The norleucine-4 modification eliminates the methionine residue susceptible to oxidation, while the D-phenylalanine-7 substitution enhances receptor binding affinity by constraining the peptide backbone in a conformation that favors MC1R interaction
Dalton CM, Szabadkai G, Carroll J
honoraria for consultancy from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk and Otsuka
Serious risks are less common, but they can include pancreatitis, gallbladder problems, dehydration-related kidney issues, and other complications